BR0211400A - Tratamento de distrofia muscular com células de sangue do cordão - Google Patents

Tratamento de distrofia muscular com células de sangue do cordão

Info

Publication number
BR0211400A
BR0211400A BR0211400-3A BR0211400A BR0211400A BR 0211400 A BR0211400 A BR 0211400A BR 0211400 A BR0211400 A BR 0211400A BR 0211400 A BR0211400 A BR 0211400A
Authority
BR
Brazil
Prior art keywords
treatment
cord blood
muscular dystrophy
blood cell
cell muscular
Prior art date
Application number
BR0211400-3A
Other languages
English (en)
Inventor
Robert H Brown
Seth P Finklestein
Original Assignee
Viacell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viacell Inc filed Critical Viacell Inc
Publication of BR0211400A publication Critical patent/BR0211400A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"TRATAMENTO DE DISTROFIA MUSCULAR COM CéLULAS DE SANGUE DO CORDãO". A presente invenção refere-se a métodos para tratar um paciente sofrendo de distrofia muscular por administração de células de sangue de cordão umbilical, por exemplo, por infusão IV.
BR0211400-3A 2001-07-23 2002-07-23 Tratamento de distrofia muscular com células de sangue do cordão BR0211400A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30722701P 2001-07-23 2001-07-23
PCT/US2002/023368 WO2003009857A1 (en) 2001-07-23 2002-07-23 Treatment of muscular dystrophy with cord blood cells

Publications (1)

Publication Number Publication Date
BR0211400A true BR0211400A (pt) 2004-11-09

Family

ID=23188804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211400-3A BR0211400A (pt) 2001-07-23 2002-07-23 Tratamento de distrofia muscular com células de sangue do cordão

Country Status (10)

Country Link
US (2) US7452529B2 (pt)
EP (1) EP1411957A1 (pt)
JP (1) JP2004536139A (pt)
CN (1) CN1638783A (pt)
BR (1) BR0211400A (pt)
CA (1) CA2455726A1 (pt)
HU (1) HUP0501108A3 (pt)
IL (1) IL160030A0 (pt)
PL (1) PL367979A1 (pt)
WO (1) WO2003009857A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
JP4902349B2 (ja) * 2004-06-11 2012-03-21 コンビ株式会社 筋ジストロフィー進行抑制組成物
US20100291042A1 (en) 2007-05-03 2010-11-18 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
CN104212760B (zh) * 2013-05-29 2017-08-08 中国科学院上海生命科学研究院 肌肉干细胞体外培养方法及其应用
JP6401445B2 (ja) * 2013-10-10 2018-10-10 国立大学法人 東京大学 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
CA2988137C (en) 2015-06-11 2021-01-26 Maria Siemionow Muscular dystrophy chimeric cells and method for treating muscular dystrophies
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674750A (en) * 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5925567A (en) * 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
CA2311729A1 (en) 1998-01-23 1999-07-29 Imclone Systems Incorporated Purified populations of stem cells
US20020051762A1 (en) * 1998-01-23 2002-05-02 Shahin Rafii Purified populations of endothelial progenitor cells

Also Published As

Publication number Publication date
US7452529B2 (en) 2008-11-18
WO2003009857A8 (en) 2003-12-24
HUP0501108A2 (en) 2006-04-28
CA2455726A1 (en) 2003-02-06
WO2003009857A1 (en) 2003-02-06
IL160030A0 (en) 2004-06-20
PL367979A1 (en) 2005-03-21
JP2004536139A (ja) 2004-12-02
US20090068156A1 (en) 2009-03-12
US20030118565A1 (en) 2003-06-26
EP1411957A1 (en) 2004-04-28
CN1638783A (zh) 2005-07-13
HUP0501108A3 (en) 2006-11-28

Similar Documents

Publication Publication Date Title
TW200503674A (en) Therapeutic agents
NO20033617L (no) Fremgangsmate for behandling av diabetes mellitus
MXPA02008770A (es) Compuestos azaciclicos para uso en el tratamiento de enfermedades relacionadas con la serotonina.
BR0315630A (pt) Administração de combinação de uma indolinona com um agente quimioterapêutico para distúrbios de proliferação celular
WO2003009857A8 (en) Treatment of muscular dystrophy with cord blood cells
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CA2502394A1 (en) Surgical articles
IL175141A0 (en) Method of therapy
BR0206160A (pt) Uso de anticorpos anti-tnf como medicamentos no tratamento de distúrbios sépticos de pacientes anêmicos
SE0001899D0 (sv) New compounds
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
DK0975595T3 (da) Kokainanaloger
GB9902047D0 (en) Chemical compounds XI
TW200510333A (en) Benzimidazole compounds
BRPI0804623A2 (pt) uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
SE0102147D0 (sv) New methods
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
TR200402275T2 (tr) Nörotik düzensizliklerin tedavisi
DK1750716T3 (da) Behandling af T-celle-lymfom under anvendelse af 10-propargyl-10-deazaaminopterin
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
EA202090558A1 (ru) Схемы лечения
DE502004002171D1 (de) Verwendung von 2-amino-2h-chinazolin-derivaten zur herstellung von therapeutischen mitteln
MXPA03011004A (es) Derivados de fenilalquiloxi-fenilo novedosos.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]